fundvisualizer.com

Lord Abbett Developing Growth R5LADTX

Performance (before sales charge)

As of 12/31/2022

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 11/30/2022
Stock
96.55%
Non-U.S. Stock
3.45%
Bond
0.00%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
0.00%
Other
0.00%

Due to rounding, percentages may not equal 100%.

Sectors

As of 11/30/2022

Basic materials

3.54%

Consumer cyclical

11.36%

Financial services

2.02%

Real estate

0.00%

Consumer defensive

2.26%

Health care

29.14%

Utilities

0.00%

Communication services

2.92%

Energy

3.23%

Industrials

16.18%

Technology

28.74%

Top 10 holdings

As of 11/30/2022

Calix Inc
2.97%
Crocs Inc
2.41%
Karuna Therapeutics Inc
2.24%
Krystal Biotech Inc
2.22%
Clear Secure Inc Ordinary Shares Class A
2.21%
Comfort Systems USA Inc
1.94%
Inspire Medical Systems Inc
1.93%
ShockWave Medical Inc
1.92%
Xenon Pharmaceuticals Inc
1.87%
Axon Enterprise Inc
1.83%
Fund assets

$2.52 Billion

Share class

Retirement

Morningstar category

Small Growth

Expense ratio

0.69%

Investment objective

Growth

Documents